CN103798899A - 一种减肥饮料及其制备方法 - Google Patents
一种减肥饮料及其制备方法 Download PDFInfo
- Publication number
- CN103798899A CN103798899A CN201210460479.8A CN201210460479A CN103798899A CN 103798899 A CN103798899 A CN 103798899A CN 201210460479 A CN201210460479 A CN 201210460479A CN 103798899 A CN103798899 A CN 103798899A
- Authority
- CN
- China
- Prior art keywords
- weight
- cla
- losing
- fat
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims description 8
- 235000013361 beverage Nutrition 0.000 title abstract description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 22
- ZMJBYMUCKBYSCP-UHFFFAOYSA-N Hydroxycitric acid Chemical compound OC(=O)C(O)C(O)(C(O)=O)CC(O)=O ZMJBYMUCKBYSCP-UHFFFAOYSA-N 0.000 claims abstract description 19
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 14
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 7
- 235000021552 granulated sugar Nutrition 0.000 claims abstract description 7
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 7
- 239000011718 vitamin C Substances 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 5
- 239000003765 sweetening agent Substances 0.000 claims abstract description 5
- 229940089491 hydroxycitric acid Drugs 0.000 claims description 17
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 15
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 abstract 1
- 235000015165 citric acid Nutrition 0.000 abstract 1
- 229940108924 conjugated linoleic acid Drugs 0.000 abstract 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 abstract 1
- 239000001509 sodium citrate Substances 0.000 abstract 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 abstract 1
- 235000011083 sodium citrates Nutrition 0.000 abstract 1
- 235000005911 diet Nutrition 0.000 description 8
- 230000037213 diet Effects 0.000 description 8
- 235000019197 fats Nutrition 0.000 description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 208000008589 Obesity Diseases 0.000 description 3
- 210000000577 adipose tissue Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- 230000035790 physiological processes and functions Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 108010011485 Aspartame Proteins 0.000 description 2
- 102000036675 Myoglobin Human genes 0.000 description 2
- 108010062374 Myoglobin Proteins 0.000 description 2
- 206010033307 Overweight Diseases 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000001497 healthy food Nutrition 0.000 description 2
- 235000020997 lean meat Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 238000004260 weight control Methods 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 244000119461 Garcinia xanthochymus Species 0.000 description 1
- 235000000885 Garcinia xanthochymus Nutrition 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- 240000004153 Hibiscus sabdariffa Species 0.000 description 1
- 235000001018 Hibiscus sabdariffa Nutrition 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 102000001746 Pancreatic alpha-Amylases Human genes 0.000 description 1
- 108010029785 Pancreatic alpha-Amylases Proteins 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001194 anti-hemostatic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000000918 epididymis Anatomy 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000002464 muscle smooth vascular Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000036581 peripheral resistance Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003161 proteinsynthetic effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000013585 weight reducing agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明提供了一种减肥产品，其特征在于，所述减肥产品为饮料，含有共轭亚油酸、羟基柠檬酸、白砂糖、柠檬酸、柠檬酸钠、维生素C、甜味剂和纯净水。该减肥产品减肥效果好、副作用小，具有非常广阔的市场前景。
Description
技术领域
本发明涉及一种减肥产品及其制备方法，具体涉及一种减肥饮料及其制备方法。
背景技术
随着人们物质生活条件的改善，肥胖病患者正逐年增加，其中尤以大中城市的发病率为高。肥胖不仅给人类的生活、工作带来诸多不便，而且影响到人类健康。肥胖会增加心脑血管疾病、糖尿病、脂肪肝、肿瘤、内分泌失调等疾病的发病率。因此减肥是肥胖者必须重视的健康问题。
目前市场上用于减肥的产品有很多，但多伴有严重的副作用：失眠、恶心、头晕、呕吐、营养不良等。因此开发一种既能达到减肥目的，又不产生副作用的减肥产品，具有重要的现实意义。
发明内容
本发明旨在提供一种减肥效果好、副作用小的减肥产品及其制备方法。
具体而言，本发明的减肥产品为饮料，含有共轭亚油酸、羟基柠檬酸、白砂糖、柠檬酸、柠檬酸钠、维生素C、甜味剂和纯净水。其中，共轭亚油酸与羟基柠檬酸的质量比优选为1:0.5-3，更优选为1:1。本发明的减肥产品的配方优选为：共轭亚油酸0.5-5g、羟基柠檬酸0.5-5g、白砂糖20-100g、柠檬酸0.5-2g、柠檬酸钠0.5-2g、维生素C0.1-1g、甜味剂0.1-0.5g和纯净水1000ml。
本发明的制备方法是用于制备上述减肥产品的方法，其特征在于，包括如下步骤：称料、混合、杀菌、装瓶。
人们早就知道有共轭亚油酸（CLA）这种物质，但它的重要生理功能的发现，还是上个世纪的后期。大量的科学研究证明，共轭亚油酸具有抗肿瘤、抗氧化、抗动脉粥样硬化、提高免疫力、提高骨骼密度、防治糖尿病等多种重要生理功能；而且还能降低动物和人体胆固醇以及甘油三酯和低密度脂蛋白胆固醇，还可以降低动物和人体脂肪、增加肌肉。共轭亚油酸作为一种新发现的营养素，目前在欧美的健康食品界，几乎已经成了预防现代文明病的万灵丹，从抗癌到预防心血管疾病、糖尿病，到体重控制上，几乎是生活在二十一世纪现代人不可或缺的健康食品。具体而言，共轭亚油酸具有如下生理功能：
1.由红花提炼，是一系列双键亚油酸，具有清除自由基，增强人体的抗氧化能力和免疫能力，促进生长发育，调节血液胆固醇和甘油三酸脂水平，防止动脉粥样硬化，促进脂肪氧化分解，促进人体蛋白合成，对人体进行全面的良性调节等作用。
2.显著增加人体的心肌肌红蛋白、骨骼肌肌红蛋白含量。肌红蛋白对氧的亲和力比血红蛋白高六倍。由于肌红蛋白的快速增加，大大提高了人体细胞贮存及转运氧气的能力，让运动训练更有效，人体活力更充沛。
3.能增强细胞膜的流动性，防止血管皮质增生，维持器官微循环的正常功能，维持细胞的正常结构及功能，增强血管的舒张能力，有效防止因严重缺氧造成的人体脏器和大脑的损伤，尤其是显著抑制因严重缺氧造成的肺、脾水肿。
4.能有效的发挥“血管清道夫”的作用，可清除血管中的垃圾，有效调节血液黏稠度，达到舒张血管、改善微循环、平稳血压的作用。有专家还认为，CLA具有扩张和松弛血管平滑肌、抑制血液运动中枢的作用，降低了血液循环的外周阻力，使血压下降，尤其是使舒张压下降更为明显。
近来有越来越多的临床研究报告都证明CLA在体重控制上的卓越表现。因为一般人减肥都只会着重在减"重"而非减"肥"，也就是说体脂肪比率不一定会有改变，减肥的人如果能配合CLA的使用，可以有效地降低体内脂肪组织相对于瘦肉组织的比率，真正地减掉肥肉，而使瘦肉比率上升。这样的好处是瘦肉越多，体内新陈代谢能力越高，于是形成良性循环，减肥将更容易达到目标。另外，临床上发现，服用CLA的减肥者，情绪稳定性较高，比较能持之以恒的进行减肥计划，睡眠和精神状况也比较好。还有研究报告指出，CLA可以避免减肥者出现溜溜球(yoyo)症状，使减肥者不至于陷于体重减而复胖，胖而复减的恶性循环中。
羟基柠檬酸(HCA)是一种柠檬酸的衍生物，广泛存在于藤黄果(GarciniaCambogia)、玫瑰茄(Hibiscus Subdariffa)等热带雨林植物中。实验室和动物实验结果表明，HCA具有调节生物体脂肪代谢水平的能力。HCA异构体中的一种：(2S,3R)-HCA，具有抑制胰α-淀粉酶和小肠α-葡糖苷酶的作用，导致体外糖代谢水平的降低（降低糖的吸收和利用率）。将实验大鼠通过基因方法预先使其成为先天性肥胖，然后给予大剂量含HCA的藤黄果提取物的研究表明，HCA可明显抑制附睾的脂肪堆积。
本发明通过将CLA和HCA配合使用，得到了减肥效果好、副作用小的减肥产品，该产品具有非常广阔的市场前景。
具体实施方式
下面结合实施例详细说明本发明，但下面的实施例仅为本发明较佳的实施方式，本发明的保护范围并不局限于此，任何熟悉本技术领域的技术人员在本发明披露的技术范围内，根据本发明的技术方案及其发明构思加以等同替换或改变，都应涵盖在本发明的保护范围之内。
实施例1
称取共轭亚油酸2g、羟基柠檬酸2g、白砂糖50g、柠檬酸2g、柠檬酸钠2g、维生素C1g、阿斯巴甜0.1g和纯净水1000ml，混匀后，杀菌、装瓶即可。
实施例2
称取共轭亚油酸2g、羟基柠檬酸2.5g、白砂糖60g、柠檬酸2g、柠檬酸钠2g、维生素C1.5g、阿斯巴甜0.1g和纯净水1000ml，混匀后，杀菌、装瓶即可。
上述减肥产品经肥胖者服用后，每月约减体重1-2kg，且均未发现副作用。
Claims (5)
1.一种减肥饮料，含有共轭亚油酸、羟基柠檬酸、白砂糖、柠檬酸、柠檬酸钠、维生素C、甜味剂和纯净水。
2.根据权利要求1所述的减肥饮料，其特征在于，共轭亚油酸与羟基柠檬酸的质量比为1:0.5-3。
3.根据权利要求2所述的减肥饮料，其特征在于，共轭亚油酸与羟基柠檬酸的质量比为1:1。
4.根据权利要求1所述的减肥饮料，其特征在于，饮料配方为：
共轭亚油酸0.5-5g、羟基柠檬酸0.5-5g、白砂糖20-100g、柠檬酸0.5-2g、柠檬酸钠0.5-2g、维生素C0.1-1g、甜味剂0.1-0.5g和纯净水1000ml。
5.权利要求1-4中任意一项所述减肥饮料的制备方法，其特征在于，包括如下步骤：称料、混合、杀菌、装瓶。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210460479.8A CN103798899A (zh) | 2012-11-15 | 2012-11-15 | 一种减肥饮料及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210460479.8A CN103798899A (zh) | 2012-11-15 | 2012-11-15 | 一种减肥饮料及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103798899A true CN103798899A (zh) | 2014-05-21 |
Family
ID=50696671
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210460479.8A Pending CN103798899A (zh) | 2012-11-15 | 2012-11-15 | 一种减肥饮料及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103798899A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108967783A (zh) * | 2018-07-11 | 2018-12-11 | 广东泓睿科技有限公司 | 一种含胶原蛋白的保健饮品及其制备方法 |
| CN111227142A (zh) * | 2020-01-17 | 2020-06-05 | 阎晓冬 | 一种健康减肥饮料 |
-
2012
- 2012-11-15 CN CN201210460479.8A patent/CN103798899A/zh active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108967783A (zh) * | 2018-07-11 | 2018-12-11 | 广东泓睿科技有限公司 | 一种含胶原蛋白的保健饮品及其制备方法 |
| CN111227142A (zh) * | 2020-01-17 | 2020-06-05 | 阎晓冬 | 一种健康减肥饮料 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sohrab et al. | Effects of pomegranate juice consumption on blood pressure and lipid profile in patients with type 2 diabetes: A single-blind randomized clinical trial | |
| US20110319497A1 (en) | Ampk activator | |
| AU2009283171A1 (en) | Hydroxybutyrate ester and medical use thereof | |
| CN102406115B (zh) | 一种防治心脑血管疾病的天然功能食品 | |
| CN101715913A (zh) | 一种活力康胶囊及其生产制作工艺 | |
| CN105770799A (zh) | 一种具有改善脑部记忆功能的颗粒制剂 | |
| CN103599137B (zh) | 一种多种微量营养元素保健品 | |
| CN104431063A (zh) | 防治心脑血管疾病的甜茶功能饮品及其制备方法 | |
| KR101415697B1 (ko) | 산사 및 진피의 복합 추출물을 유효성분으로 함유하는 비만 또는 지질 관련 대사성 질환의 치료 또는 예방용 약학 조성물 | |
| CN100515430C (zh) | 补充钙镁和维生素d的药品制剂 | |
| CN103798899A (zh) | 一种减肥饮料及其制备方法 | |
| CN104126833B (zh) | 一种刺玫果功能性饮料的制备方法 | |
| CN102670978A (zh) | 一种黄精复方颗粒剂及其制备方法 | |
| CN102552574A (zh) | 一种减肥功能的保健药物配方 | |
| CN107927292A (zh) | 一种抗氧化的蛹虫草压片糖果生产方法 | |
| CN103621871B (zh) | 一种复合氨基酸保健品及其制备方法 | |
| CN103798066A (zh) | 一种有机富硒原料的制作方法及其用该原料制成的有机富硒产品 | |
| CN101884408A (zh) | 一种银杏叶浸提液及其制备方法 | |
| CN103798416A (zh) | 一种减肥调和油及其制备方法 | |
| CN103800311A (zh) | 一种减肥口含片及其制备方法 | |
| CN1679593A (zh) | 一种含有α－亚麻酸游离酸、大豆磷脂和维生素E的复合制剂 | |
| CN102524763A (zh) | 沙棘油软胶囊及制备方法 | |
| LeBaron et al. | Effects of an H2-infused, Nitric Oxide-Producing Functional Beverage on Exercise and Cognitive Performance | |
| CN101019846A (zh) | 含丙酮酸及其盐的胶囊的制备 | |
| CN103798481A (zh) | 一种减肥巧克力及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140521 |